Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Is there any current information about who is holding the convertibles?
I do hope it is not Kansas City Dentists , from an earlier generation.
I agree probably with CofE that this is a buy at 8.16p
As a positive long term holder , with a loss of £10k here, I look forward to quarterly reports which not only itemise growing , POG and possibly other, POX production but also include some estimates of POX production profitability in view of debts.
The one i received late yesterday included:
Whereas Professor Jack Cuzick, an expert in cancer prevention, is particularly excited about building the evidence that might lead to low-dose aspirin being recommended “as a means of preventing cancer”.
Aside from a scientific curiosity about the causal mechanism, my initial reaction was "you cannot be serious".
Please can someone knowledgeable give a scholarly view or simple reference.
Is it wise to expect 2019 guidance, including POX plans (including estimated costs), by the end of January?
Ben18
As a lth of POG I was content with ICBC as bankers to IRC, perhaps the appropriate diplomatic description of Gazprombank is well connected ?
Alas IRC will never be a Champions League risk!
Happy Christmas everyone.
Thanks very much for the official CRUK news about January.
Does anyone know anything about the nebulous cunning planning for a referendum about a referendum? I guess it's a secret.
Happy Christmas and New Year!
Sincere best wishes and good luck.
At the risk of being accused of ramping South London NHS hospitals : St. Thomas and Guy's are confidence inspiring too. I fell over and had hand surgery on my little finger.
I guess the UK sites for Scancell clinical trials like most things are important but not very?
I agree...but IF the BoD have more cash than appropriate (risky) asset increases maybe as a possible option they should consider purchasing derivatives to protect future cashflows as well as dividends?
inanaco the wise,
On the Scib1-Trigrid 2- PD-1 trial , i had assumed rather than go immediately to 4mg or 8 mg there would be a ramp up for safety reasons.
However I haven't the slightest idea what might currently concern the FDA about this USA-UK trial.
Please will you or others speculate.
"Scancell and Ichor are working with the FDA to provide the necessary information to enable initiation of the trial. In parallel, Scancell is continuing to work on the operational activities required to initiate clinical sites in the US and UK."
In the unlikely event, of significant FDA delay , I guess this trial could proceed in the UK only?